SecBot SecBot
PRESS-RELEASE ·Filed Mar 19, 2026

TEVA

Teva Pharmaceutical Industries Ltd
NEUTRAL
Impact 3/10
Horizonweeks Processed8mo ago WireGlobeNewswire
Actionable Insight • Neutral

Traders should prepare for the April 29 earnings release, using the Aide Memoire as a reference for management's prior commentary and expectations. Monitor for updates on the Pivot to Growth strategy, generics performance, and debt levels during the call.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$28.70
T+0 close · Mar 19, 2026 · via day close
Latest settled
+20.68%
T+60 · $34.63
Vs SPY
+6.26%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 20 $28.70entry
  2. T+1 · 8mo ago +0.18%α −0.93% · $28.75
  3. T+5 · 8mo ago +0.11%α +2.26% · $28.73
  4. T+20 · 7mo ago +11.50%α +2.18% · $32.00
  5. T+60 · 5mo ago +20.68%α +6.26% · $34.63
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Teva Pharmaceutical announced the date for its Q1 2026 earnings release on April 29, 2026, and published an Aide Memoire to assist investors in preparing for the results. The documents provide no actual financial data but confirm the timing of the upcoming earnings announcement and reiterate forward-looking statements about the company's strategic transformation.

Key Facts

  • Teva will release Q1 2026 financial results on April 29, 2026, at 7:00 a.m. ET
  • A conference call and webcast will follow at 8:00 a.m. ET on the same day
  • An Aide Memoire has been posted to the investor relations website, based on previously disclosed information and external data
  • No new financial results, guidance, or material updates were provided in either press release

Financial Impact

No immediate financial impact, no new data disclosed

Risk Factors

  • Forward-looking statements are subject to risks including execution of the growth strategy, competitive pressures, and high indebtedness
  • No assurance that actual results will align with prior management commentary or market expectations

Market Snapshot

Exchange
OTC

Investment Themes

Documents Analyzed

This report is based on 2 press releases from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3259456
PRESS-RELEASE Data (Synthetic)press-3259458

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (11h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 19, 2026